Julie Hambleton
CIK: 0001578771
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Jun 26, 2026ERAS
Erasca, Inc.
Award(A)DirectStock option (right to buy)
29.9K shares- - Aug 14, 2025IGMS
IGM Biosciences, Inc.
Disposition(D)Direct2K shares- - Jul 1, 2025SWTX
SpringWorks Therapeutics, Inc.
Disposition(D)Direct14.2K shares- - Jun 24, 2025ERAS
Erasca, Inc.
Award(A)DirectStock option (right to buy)
120K shares- - May 14, 2025SWTX
SpringWorks Therapeutics, Inc.
Award(A)Direct10.1K shares- - Feb 10, 2025SWTX
SpringWorks Therapeutics, Inc.
Sale(S)Direct13.8K shares at avg. $53.01$730K - Feb 10, 2025SWTX
SpringWorks Therapeutics, Inc.
Exercise(M)Direct13.8K shares at avg. $32.27$444K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 26, 2026 | ERAS Erasca, Inc. | Award(A) Stock option (right to buy) | 29,888 | - | - | Direct |
| Aug 14, 2025 | IGMS IGM Biosciences, Inc. | Disposition(D) | 2,000 | - | - | Direct |
| Jul 1, 2025 | SWTX SpringWorks Therapeutics, Inc. | Disposition(D) | 14,155 | - | - | Direct |
| Jun 24, 2025 | ERAS Erasca, Inc. | Award(A) Stock option (right to buy) | 120,000 | - | - | Direct |
| May 14, 2025 | SWTX SpringWorks Therapeutics, Inc. | Award(A) | 10,060 | - | - | Direct |
| Feb 10, 2025 | SWTX SpringWorks Therapeutics, Inc. | Sale(S) | 13,774 | $53.01 | $730,207 | Direct |
| Feb 10, 2025 | SWTX SpringWorks Therapeutics, Inc. | Exercise(M) | 13,774 | $32.27 | $444,487 | Direct |
1-7 of 7 transactions
About Hambleton Julie
Hambleton Julie (SEC CIK 0001578771) files insider reports with the SEC as Director of Erasca, Inc. (ERAS), Director of IGM Biosciences, Inc. (IGMS) and Director of SpringWorks Therapeutics, Inc. (SWTX).
Signal8 holds 6 ownership filings by Hambleton Julie, all Form 4s, filed between Feb 12, 2025 and Jun 29, 2026. Those filings report 7 transactions, from Feb 10, 2025 to Jun 26, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Hambleton Julie's filings is in SAN DIEGO, CA.
Recent filings by Hambleton Julie
- Jun 26, 2026: Grant or award of ERAS derivative securities (Form 4, code A).
- Aug 14, 2025: Disposition to issuer transaction of IGMS shares (Form 4, code D).
- Jul 1, 2025: Disposition to issuer transaction of SWTX shares (Form 4, code D).
- Jun 24, 2025: Grant or award of ERAS derivative securities (Form 4, code A).
- May 14, 2025: Grant or award of SWTX shares (Form 4, code A).
Other insiders filing for Erasca, Inc. (ERAS)
- Fuchs Charles S., President, R&D
- Start Valerie Denise Harding, Director
- LIU JEAN I, Director
- Multani Pratik S, Director
- Casdin Alexander W., Director
- Bristol James Arthur, Director